Patients with a history of intracranial hemorrhage have had few safe treatment options for nonvalvular atrial fibrillation. A new study of the Watchman device suggests that may be changing.
Our electrophysiologists share their approach to deciding between ablation and medical management along with a wealth of insights for care before and after the ablation procedure.
Debate around findings of the multicenter CABANA study of ablation versus drug therapy for atrial fibrillation shouldn’t distract from why patients seek ablation in the first place: symptom relief.
Findings from three Cleveland Clinic real-world studies suggest a wider range of patients stand to benefit from the left atrial appendage closure device.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Dr. Oussama Wazni suspects more patients with AF could benefit from early catheter ablation. So he’s leading two multicenter trials to see if his suspicions pan out.
Fistula formation is a very rare but recognized complication of atrial ablation. This striking case study illustrates some lessons in its recognition and management.
The dramatic case of a 56-year-old with an ICD for radiation-associated heart disease shows why performing high-risk lead extractions in a hybrid OR with surgical backup can be critical.
What’s the potential clinical role of the recently reported noninvasive EP-guided cardiac radioablation therapy for ventricular tachycardia? A Cleveland Clinic expert weighs in.
When Dr. Oussama Wazni takes over leadership of Cleveland Clinic’s EP section in September, he’ll be doubling down on linking research with practice to take on clinical challenges.
As implantable cardiac device use grows, so do infections from abandoned device leads. A new study quantifies the effect on patient outcomes — and the lead author says guideline changes are in store.